Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Show simple item record

dc.contributor.author Van der Mescht, Mieke Adri
dc.contributor.author De Beer, Zelda
dc.contributor.author Steel, Helen C.
dc.contributor.author Anderson, Ronald
dc.contributor.author Masenge, Andries
dc.contributor.author Moore, Penny L.
dc.contributor.author Bastard, Paul
dc.contributor.author Casanova, Jean-Laurent
dc.contributor.author Abdullah, Fareed
dc.contributor.author Ueckermann, Veronica
dc.contributor.author Rossouw, Theresa M.
dc.date.accessioned 2024-08-28T07:52:25Z
dc.date.available 2024-08-28T07:52:25Z
dc.date.issued 2024-09
dc.description DATA AVAILABILITY : The datasets analyzed for this study can be made available on request. en_US
dc.description.abstract The African continent reported the least number of COVID-19 cases and deaths of all the continents, although the exact reasons for this are still unclear. In addition, little is known about the immunological profiles associated with COVID-19 mortality in Africa. The present study compared clinical and immunological parameters, as well as treatment outcomes in patients admitted with COVID-19 in Pretoria, South Africa, to determine if these parameters correlated with mortality in this population. The in-hospital mortality rate for the cohort was 15.79%. The mortality rate in people living with HIV (PLWH) was 10.81% and 17.16% in people without HIV (p = 0.395). No differences in age (p = 0.099), gender (p = 0.127) or comorbidities were found between deceased patients and those who survived. All four of the PLWH who died had a CD4+ T-cell count <200 cells/mm3, a significantly higher HIV viral load than those who survived (p = 0.009), and none were receiving antiretroviral therapy. Seven of 174 (4%) patients had evidence of auto-antibodies neutralizing Type 1 interferons (IFNs). Two of the them died, and their presence was significantly associated with mortality (p = 0.042). In the adjusted model, the only clinical parameters associated with mortality were: higher fraction of inspired oxygen (FiO2) (OR: 3.308, p = 0.011) indicating a greater need for oxygen, high creatinine (OR: 4.424, p = 0.001) and lower platelet counts (OR: 0.203, p = 0.009), possibly secondary to immunothrombosis. Overall, expression of the co-receptor CD86 (p = 0.021) on monocytes and percentages of CD8+ effector memory 2 T-cells (OR: 0.45, p = 0.027) was lower in deceased patients. Decreased CD86 expression impairs the development and survival of effector memory T-cells. Deceased patients had higher concentrations of RANTES (p = 0.003), eotaxin (p = 0.003) and interleukin (IL)-8 (p < 0.001), all involved in the activation and recruitment of innate immune cells. They also had lower concentrations of transforming growth factor (TGF)-β1 (p = 0.40), indicating an impaired anti-inflammatory response. The immunological profile associated with COVID-19 mortality in South Africa points to the role of aberrate innate immune responses. en_US
dc.description.department Immunology en_US
dc.description.department Internal Medicine en_US
dc.description.department School of Health Systems and Public Health (SHSPH) en_US
dc.description.department Statistics en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The South African Medical Research Council Self-Initiated Research Grant (SAMRC SIR) funded the project. The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute, the Rockefeller University, the St. Giles Foundation, the National Institutes of Health (NIH) and R21AI160576), the National Center for Advancing Translational Sciences (NCATS), the NIH Clinical and Translational Science Award (CTSA) program, the Fisher Center for Alzheimer's Research Foundation, the Meyer Foundation, the JPB Foundation, the Stavros Niarchos Foundation (SNF) as part of its grant to the SNF Institute for Global Infectious Disease Research at the Rockefeller University, the “Investissement d'Avenir” program launched by the French Government and implemented by the Agence Nationale de la Recherche (ANR), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, the French Foundation for Medical Research (FRM), the European Union's Horizon 2020 research and innovation program, the Square Foundation, Grandir - Fonds de solidarité pour l'enfance, the Fondation du Souffle, the SCOR Corporate Foundation for Science, Battersea & Bowery Advisory Group, The French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19), Institut National de la Santé et de la Recherche Médicale (INSERM), REACTing-INSERM, Paris Cité University, Imagine Institute and William E. Ford, General Atlantic's Chairman and Chief Executive Officer, Gabriel Caillaux, General Atlantic's Co-President, Managing Director and Head of Business in EMEA, and the General Atlantic Foundation. A.-L.N. was supported by the Imagine Institute international PhD program (with the support of the Fondation Bettencourt-Schueller) and the FRM, the French Foundation for Medical Research, the MD-PhD program of the Imagine Institute (with the support of the Fondation Bettencourt-Schueller), and a “Poste CCA-INSERM-Bettencourt” (with the support of the Fondation Bettencourt-Schueller). en_US
dc.description.uri https://www.elsevier.com/locate/yclim en_US
dc.identifier.citation Van der Mescht, M.A., D Beer, Z., Steel, H.C. et al. 2024, 'Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa', Clinical Immunology, vol. 266, art. 110323, pp. 1-11, doi : 10.1016/j.clim.2024.110323. en_US
dc.identifier.issn 1521-6616
dc.identifier.other 10.1016/j.clim.2024.110323
dc.identifier.uri http://hdl.handle.net/2263/97902
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.rights © 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC license. en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject Mortality en_US
dc.subject People living with HIV (PLWHIV) en_US
dc.subject CD86 en_US
dc.subject Cytokines en_US
dc.subject Type 1 IFN antibodies en_US
dc.subject Type 1 interferons (IFNs) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record